Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia

Blood

Volumn 120, Issue 4, 2012, Pages 748-760

  Josephson, Cassandra D ^a,b   Granger, Suzanne ^c   Assmann, Susan F ^c   Castillejo, Marta Inés ^a,b   Strauss, Ronald G ^d   Slichter, Sherrill J ^e,f   Steiner, Marie E ^g   Journeycake, Janna M ^h   Thornburg, Courtney D ⁱ   Bussel, James ^j   Grabowski, Eric F ^k   Neufeld, Ellis J ^k   Savage, William ^l   Sloan, Steven R ^k  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

^k HARVARD UNIVERSITY   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; AUTOTRANSPLANTATION; BLEEDING; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT INDUCED HYPOPROLIFERATIVE THROMBOCYTOPENIA;

EID: 84864423026     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-389569     Document Type: Article

References (24)

1. Roy AJ, Jaffe N, Djerassi I. Prophylactic platelet transfusions in children with acute leukemia: a dose response study. Transfusion. 1973;13(5):283-290.
2. Higby DJ, Cohen E, Holland JF, Sinks L. The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion. 1974;14(5):440-446.
3. Murphy S, Litwin S, Herring LM, et al. Indications for platelet transfusion in children with acute leukemia. Am J Hematol. 1982;12(4):347-356. (Pubitemid 12073151)
4. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med. 1997;337(26):1870-1875.
5. Ilett SJ, Lilleyman JS. Platelet transfusion requirements of children with newly diagnosed lymphoblastic leukaemia. Acta Haematol. 1979;62(2):86-89. (Pubitemid 9256425)
6. Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010;362(7):600-613.
7. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207-214. (Pubitemid 11167383)
8. Zelen M. The randomization and stratification of patients to clinical trials. J Chron Dis. 1974;27(7-8):365-375.
9. SAS/STAT software Version 9.2. Cary, NC: SAS Institute; 2000-2008.
10. Cox DR, Oakes D. Analysis of Survival Data. London, United Kingdom: Chapman & Hall; 1984.
11. McPherson ME, Owusu BY, August KJ, et al. Platelet transfusion requirements are associated with endothelial cell injury and angiogenesis during allogeneic hematopoietic stem cell transplantation [abstract]. Blood (ASH Annual Meeting Abstracts). 2010;116(21):Abstract 3487.
12. Walshe TE, Dole VS, Maharaj AS, Patten IS, Wagner DD, D'Amore PA. Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling. Arterioscler Thromb Vasc Biol. 2009;29(8):1185-1192.
13. Danielli JF. Capillary permeability and oedema in the perfused frog. J Physiol. 1940;98(1):109-129.
14. Solanilla A, Villeneuve J, Auguste P, et al. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis. Rheumatology (Oxford). 2009;48(9):1036-1044.
15. Mochizuki N. Vascular integrity mediated by vascular endothelial cadherin and regulated by sphingosine 1-phosphate and angiopoietin-1. Circ J. 2009;73(12):2183-2191.
16. He P. Beyond tie-ing up endothelial adhesion: new insights into the action of angiopoietin-1 in regulation of microvessel permeability. Cardiovasc Res. 2009;83(1):1-2.
17. Ulrych T, Böhm A, Polzin A, et al. Release of sphingosine-1- phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost. 2011;9(4):790-798.
18. Kitchens CS. Amelioration of endothelial abnormalities by prednisone in experimental thrombocytopenia in the rabbit. J Clin Invest. 1977;60(5):1129- 1134. (Pubitemid 8223139)
19. Matalon SV, Wangensteen OD. Pulmonary capillary filtration and reflection coefficients in the newborn rabbit. Microvasc Res. 1977;14(1):99-110. (Pubitemid 8153801)
20. Milligan RG Jr, Wangensteen OD. Pulmonary microvascular filtration and reflection coefficients in two- and four-week old rabbits. Microvasc Res. 1978;15(3):331-338. (Pubitemid 8371183)
21. de Vos FY, Willemse PH, de Vries EG, Gietema JA. Endothelial cell effects of cytotoxics: balance between desired and unwanted effects. Cancer Treat Rev. 2004;30(6):495-513. (Pubitemid 39157851)
22. Moroz V, Machin D, Faldum A, et al. Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project. Eur J Cancer. 2011;47(4):561-571.
23. Pulte D, Gondos A, Brenner H. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst. 2008;100(18):1301-1309.
24. Nachman RL, Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med. 2008;359(12):1261-1270.